105 related articles for article (PubMed ID: 3544878)
1. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock.
Lefer AM
Am J Physiol; 1987 Feb; 252(2 Pt 2):R193-205. PubMed ID: 3544878
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
Lefer AM
Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
[TBL] [Abstract][Full Text] [Related]
3. [The role of the myocardial depressant factor in the pathogenesis of the shock].
Pagni E
Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
[TBL] [Abstract][Full Text] [Related]
4. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple systems organ failure.
Lefer AM
Crit Care Clin; 1989 Apr; 5(2):331-52. PubMed ID: 2650821
[TBL] [Abstract][Full Text] [Related]
5. Positive feedback actions of a myocardial depressant factor in circulatory shock.
Lefer AM
Tex Rep Biol Med; 1979; 39():209-16. PubMed ID: 553307
[No Abstract] [Full Text] [Related]
6. MDF: its participation in the pathophysiology of shock.
Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
[No Abstract] [Full Text] [Related]
7. Thromboxane A2 and leukotrienes are eicosanoid mediators of shock and ischemic disorders.
Lefer AM
Prog Clin Biol Res; 1988; 264():101-14. PubMed ID: 2837782
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms that inhibit the formation and manifestation of the myocardial depressant factor in shock states].
Lefer AM
Khirurgiia (Sofiia); 1980; 33(5):377-85. PubMed ID: 7003214
[No Abstract] [Full Text] [Related]
9. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
Lefer AM
Prog Clin Biol Res; 1983; 111():111-23. PubMed ID: 6191336
[No Abstract] [Full Text] [Related]
10. Eicosanoids as mediators of ischemia and shock.
Lefer AM
Fed Proc; 1985 Feb; 44(2):275-80. PubMed ID: 2981745
[TBL] [Abstract][Full Text] [Related]
11. Current concepts on myocardial depressant factor.
Giuseppe T; Marco S; Sigfrido I; Pasquale M; Giorgio C
Mater Med Pol; 1989; 21(1):53-6. PubMed ID: 2699345
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock.
Lefer AM; Lefer DJ
Annu Rev Pharmacol Toxicol; 1993; 33():71-90. PubMed ID: 8494355
[TBL] [Abstract][Full Text] [Related]
13. [Physiological effect of myocardial depressant factor (author's transl)].
Kosugi I; Yamaguchi Y; Okada K
Kokyu To Junkan; 1975 Sep; 23(9):805-10. PubMed ID: 1239066
[No Abstract] [Full Text] [Related]
14. Prostaglandins, leukotrienes, and platelet-activating factor in shock.
Feuerstein G; Hallenbeck JM
Annu Rev Pharmacol Toxicol; 1987; 27():301-13. PubMed ID: 3034139
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor and shock.
Feuerstein G; Siren AL
Prog Biochem Pharmacol; 1988; 22():181-90. PubMed ID: 3043432
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of platelet-activating factor-induced cardiac depression in the isolated perfused rat heart.
Stahl GL; Lefer AM
Circ Shock; 1987; 23(3):165-77. PubMed ID: 2827906
[TBL] [Abstract][Full Text] [Related]
17. A pharmacological approach to thromboxane receptor antagonism.
Lefer AM; Darius H
Fed Proc; 1987 Jan; 46(1):144-8. PubMed ID: 2948838
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive humoral mediators and the splanchnic circulation in shock.
Bulkley GB; Meilahn JE
Prog Clin Biol Res; 1988; 264():91-100. PubMed ID: 3289039
[No Abstract] [Full Text] [Related]
19. [Endogenous shock substances: research trends].
Okada K
Nihon Rinsho; 1980; 38(4):1836-42. PubMed ID: 7411893
[No Abstract] [Full Text] [Related]
20. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
Hock CE; Lefer AM
Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
